Using LNT-229 glioma cells, we demonstrated that stable TIGAR gene silencing (1) was associated with higher ROS levels under hypoxic conditions, (2) increased cell death in hypoxia, and (3) sensitized cells to radiation and temozolomide. The gene discussed is TIGAR; the disease is glioma.